Press

Unlearn’s 2024 Achievements Drive Innovation in AI for Clinical Development

Unlearn to use APST data to develop digital twin models for ALS trials

Unlearn to use APST clinical data to create ‘digital twins’ of ALS patients

Unlearn on shaving millions off clinical trial budgets with digital twins

How Is Artificial Intelligence Changing the Clinical Trials Landscape?

How AI-Generated Digital Twins Are Speeding Up Clinical Development

ProJenX and Unlearn partner to use AI-generated digital twins in ALS trial

Health AI 35: What to know, who to watch

Unlearn Announces Leadership Transition to Accelerate Commercial Growth and AI Innovation

How digital twins could support more affordable Alzheimer’s research

Unlearn’s AI-Powered Clinical Trials with AbbVie and Johnson & Johnson

Steve Herne Joins Unlearn’s Executive Team as Chief Commercial Officer

Pharma’s cultural barriers could blunt AI progress despite pressures for more efficient drug approvals

The AI-Generated Population Is Here, and They’re Ready to Work

As AI proliferates in pharma, regulators look to catch up in clinical trials

Beyond the Black Box: Tailoring AI Regulation in Healthcare

Unlearn CEO: Digital twins could slash clinical trial patient enrollment by 25% or more

Charles Fisher, Ph.D., CEO & Founder of Unlearn – Interview Series

Unlearn launches TwinRCT 3.0 to enhance Phase II trials

Exploring Functional Uses Of AI In Life Sciences